News | 11 June 2012
States with pharmaceutical-payment transparency legislation saw no substantial increase in physician orders for generic medications. By Kevin B. O'Reilly, amednews staff. Posted June 11, 2012. Two states that require pharmaceutical companies to report ...
Click on the link to read the full article at American Medical News
(This link will open in a new window)